We are live on ! Find out more
AC

Almitas Capital Portfolio holdings

AUM $417M
1-Year Est. Return 22.81%
This Fund
S&P 500
This Quarter Est. Return
+1.7%
1 Year Est. Return
+22.81%
3 Year Est. Return
+86.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$417M
AUM Growth
-$25.2M
Cap. Flow
-$24.7M
Cap. Flow %
-5.92%
Top 10 Hldgs %
52.38%
Holding
150
New
35
Increased
33
Reduced
22
Closed
21

Top Buys

Rank Stock Value
1
TYG
Tortoise Energy Infrastructure Corp
TYG
+$7.43M
2
ASA
ASA Gold and Precious Metals
ASA
+$6.48M
3
MFM
Aberdeen Municipal Income Fund
MFM
+$4.77M
4
AOR icon
iShares Core 60/40 Balanced Allocation ETF
AOR
+$4.76M
5
SCHH icon
Schwab US REIT ETF
SCHH
+$4.63M

Top Sells

Rank Stock Value
1
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$17.7M
2
NQP
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
+$12.6M
3
FBTC icon
Fidelity Wise Origin Bitcoin Fund
FBTC
+$10.8M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$8.43M
5
DSGN icon
Design Therapeutics
DSGN
+$6.28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 69.24%
2 Healthcare 14.39%
3 Financials 6.53%
4 Real Estate 5.02%
5 Consumer Discretionary 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBTC icon
1
Fidelity Wise Origin Bitcoin Fund
FBTC
$14.4B
$69.7M 16.69%
1,364,522
-172,115
-11% -$10.8M
BTT icon
2
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
$33.8M 8.1%
1,485,213
-800
-0.1% -$18.2K
ASA
3
ASA Gold and Precious Metals
ASA
$1.19B
$32.7M 7.84%
629,121
+103,455
+20% +$6.48M
AMLX icon
4
Amylyx Pharmaceuticals
AMLX
$3.87B
$17.5M 4.2%
974,881
-1,147,716
-54% -$17.7M
DSGN icon
5
Design Therapeutics
DSGN
$946M
$14.9M 3.56%
1,026,893
-503,442
-33% -$6.28M
PDX
6
PIMCO Dynamic Income Strategy Fund
PDX
$968M
$11.4M 2.74%
549,495
+8,003
+1% +$169K
CRF
7
Cornerstone Total Return Fund
CRF
$1.1B
$11.3M 2.7%
1,572,309
+456,961
+41% +$3.28M
CNNE icon
8
Cannae Holdings
CNNE
$678M
$10.7M 2.56%
741,318
– –
MEGI
9
NYLIM CBRE Global Infrastructure Megatrends Term Fund
MEGI
$771M
$8.47M 2.03%
557,462
+241,329
+76% +$3.66M
LYEL icon
10
Lyell Immunopharma
LYEL
$356M
$8.17M 1.96%
581,407
+3,600
+0.6% +$65.2K
BMEZ icon
11
BlackRock Health Sciences Trust II
BMEZ
$1.05B
$7.78M 1.87%
507,095
+700
+0.1% +$10.1K
ANTX icon
12
AN2 Therapeutics
ANTX
$211M
$7.11M 1.7%
1,469,129
-10,000
-0.7% -$43K
TYG
13
Tortoise Energy Infrastructure Corp
TYG
$1.1B
$6.94M 1.66%
+161,872
New +$7.43M
PCQ
14
Pimco California Municipal Income Fund
PCQ
$166M
$6.37M 1.53%
710,604
+93,589
+15% +$822K
SPXX icon
15
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$346M
$6.09M 1.46%
326,907
+238,355
+269% +$4.22M
ALXO icon
16
ALX Oncology
ALXO
$277M
$6.08M 1.46%
2,938,431
-235,403
-7% -$421K
FSSL
17
FS Specialty Lending Fund
FSSL
$889M
$5.99M 1.44%
537,295
+268,485
+100% +$3.17M
SDHY
18
PGIM Short Duration High Yield Opportunities Fund
SDHY
$394M
$5.98M 1.43%
364,674
+185,753
+104% +$2.98M
CLM icon
19
Cornerstone Strategic Value Fund
CLM
$2.07B
$5M 1.2%
661,789
+219,775
+50% +$1.65M
MFM
20
Aberdeen Municipal Income Fund
MFM
$221M
$4.94M 1.18%
+878,531
New +$4.77M
AOR icon
21
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.76B
$4.86M 1.16%
+69,946
New +$4.76M
SCHH icon
22
Schwab US REIT ETF
SCHH
$11.3B
$4.7M 1.13%
+198,600
New +$4.63M
DSM
23
BNY Mellon Strategic Municipal Bond Fund
DSM
$288M
$4.66M 1.12%
757,999
-168,302
-18% -$1.02M
USA icon
24
Liberty All-Star Equity Fund
USA
$1.85B
$4.64M 1.11%
798,342
+402,857
+102% +$2.32M
JOF
25
Japan Smaller Capitalization Fund
JOF
$358M
$4.55M 1.09%
386,375
-16,581
-4% -$189K
1
2 3 4 5

Similar funds

CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return
SCM
Seascape Capital Management Portsmouth, New Hampshire $417M AUM 41.98% 1-Year Est. Return
EWM
EPG Wealth Management Atlanta, Georgia $417M AUM 34.31% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $417M AUM 12.55% 1-Year Est. Return
VA
Vestwell Advisors New York $418M AUM 17.76% 1-Year Est. Return
CWM
Concentrum Wealth Management San Jose, California $418M AUM 40.93% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $418M AUM 18.65% 1-Year Est. Return

Almitas Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Almitas Capital held 150 positions worth $417M, down 5.7% from $443M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Almitas Capital withdrew a net $24.7M in Q2 2026, closing 21 positions and reducing 22 holdings. Its most notable exit was Nuveen Pennsylvania Quality Municipal Income Fund, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, up from 66% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Almitas Capital opened a new position in Tortoise Energy Infrastructure Corp worth $6.94M.

  • Almitas Capital's largest Q2 2026 buy was Tortoise Energy Infrastructure Corp: 161,872 shares worth $6.94M.
  • Almitas Capital added most to ASA Gold and Precious Metals in Q2 2026, an estimated $6.48M increase.
  • Almitas Capital's biggest Q2 2026 reduction was Amylyx Pharmaceuticals, cutting an estimated $17.7M.
  • Almitas Capital fully exited Nuveen Pennsylvania Quality Municipal Income Fund in Q2 2026, selling an estimated $12.6M.
  • Almitas Capital's ten largest holdings make up 52% of its $417M portfolio in Q2 2026.
  • Almitas Capital opened 35 new positions and closed 21 in Q2 2026.
  • Almitas Capital's portfolio value fell 5.7% quarter-over-quarter to $417M.

Based on Almitas Capital's 13F filing for Q2 2026, filed 17 Aug 2026.